Patent: 9,533,979
✉ Email this page to a colleague
Summary for Patent: 9,533,979
Title: | Amino-derivatives as novel inhibitors of histone deacetylase |
Abstract: | This invention comprises the novel compounds of formula (I) ##STR00001## wherein n, m, t, R.sup.1, R.sup.2, L, Q, X, Y, Z and ##STR00002## have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine. |
Inventor(s): | Angibaud; Patrick Rene (Fontaine-Bellinger, FR), Van Emelen; Kristof (Sint-Niklaas, BE), Poncelet; Virginie Sophie (Le Manoir sur Seine, FR), Roux; Bruno (Saint Leeger du Bourg-Denis, FR) |
Assignee: | Janssen Pharmaceutica NV (Beerse, BE) |
Application Number: | 14/538,317 |
Patent Claims: | see list of patent claims |
Details for Patent 9,533,979
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2022-03-13 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2022-03-13 |
Genentech, Inc. | HERCEPTIN HYLECTA | trastuzumab and hyaluronidase-oysk | Injection | 761106 | 02/28/2019 | ⤷ Try a Trial | 2022-03-13 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |